Oct 13, 2026 · 1 hr 6 min · 12 segments
Can we change how we age? And how much of what's being sold in the name of longevity is backed by human evidence? In this episode, I sit down with Professor Andrea Maier, an internal medicine…
Andrea MaierGuest
Azra AlagicHost
Where do you think the longevity field is currently running furthest ahead of the evidence?

It's really the lovely team I'm working with and especially the entire field, which is growing so nicely.

We have a wellness sector, which is hugely expanding to bring products to people who want to live longer and want to be better.

But with that excitement, there is also lots of risks that products are on the market which might not have the quality standard we normally would have because of that ask of the consumers to push out consumer goods and to be able to implement it already in clinical practice.

And that's what I'm really advocating for, that we sometimes have to step a little bit back and say, okay, what are we really doing? Is it working? The evidence generation is so important.

And that's what we are thriving for at the NUS Academy for Health and Longevity, to really make sure whatever enters in the consumer market into medical practices, that we know that this is really going to work, making a difference in consumer lives.

Not only that consumers are feeling good, because that could be placebo, but they are really better.

And just to follow on from that, there are lots of things on the market at the moment in the longevity space.

Do you think that there are some of these products that are out there that are claiming longevity interventions that just have no business whatsoever in that claim?

Where do you think the longevity field is currently running furthest ahead of the evidence?

It's really the lovely team I'm working with and especially the entire field, which is growing so nicely.

We have a wellness sector, which is hugely expanding to bring products to people who want to live longer and want to be better.

But with that excitement, there is also lots of risks that products are on the market which might not have the quality standard we normally would have because of that ask of the consumers to push out consumer goods and to be able to implement it already in clinical practice.

And that's what I'm really advocating for, that we sometimes have to step a little bit back and say, okay, what are we really doing? Is it working? The evidence generation is so important.

And that's what we are thriving for at the NUS Academy for Health and Longevity, to really make sure whatever enters in the consumer market into medical practices, that we know that this is really going to work, making a difference in consumer lives.

Not only that consumers are feeling good, because that could be placebo, but they are really better.

And just to follow on from that, there are lots of things on the market at the moment in the longevity space.

Do you think that there are some of these products that are out there that are claiming longevity interventions that just have no business whatsoever in that claim?
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.